CPD-Accredited NMD4C Webinar | Up and Coming Stars in NMD | December 1st
Up and Coming Stars in NMD
Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) are pleased to invite you to a webinar on up and coming stars in NMD.
This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular disease.
NMD4C and MDC are providing organizational and technical support, and this is an independent clinical/academic webinar with no industry sponsorship.
The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Tuesday December 1st, 5:00pm -6:30pm EST
Register now!
Agenda
Chair: Dr. Natasha Chang
Format: 4 x 20 min presentations (including questions) from early-career researchers and clinicians describing their journey to achieving their present position and provide an overview of their research.
Speakers:
1. Dr. Mireille Khacho (University of Ottawa): Shape-changing mitochondria: New players in muscle stem cell regulation
2. Dr. Gerald Pfeffer (University of Calgary): Alternative approaches to diagnosis of neurogenetic diseases
3. Dr. Élise Duchesne (Université du Québec à Chicoutimi): The skeletal muscle under a multifaced perspective
4. Dr. Natasha Chang (McGill University): Muscle stem cells and their contribution to DMD
Learning Objectives:
1. Engage with early career investigators and learn how they obtained independent academic positions
2. Learn how early career investigators are tackling neuromuscular diseases
3. Opportunity to ask questions regarding their academic career paths or research programs
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.